Advanced search
Publication Cover
Risk Management and Healthcare Policy Volume 16, 2023 - Issue
Submit an article Journal homepage
188
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer in China

Xin Zhang1 Department of Clinical Pharmacy, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, People’s Republic of ChinaView further author information
,
Huixian Zhang1 Department of Clinical Pharmacy, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-6758-7243View further author information
ORCID Icon,
Lan-Fang Li1 Department of Clinical Pharmacy, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, People’s Republic of ChinaView further author information
,
Lei Feng1 Department of Clinical Pharmacy, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, People’s Republic of ChinaView further author information
&
Qiao Liu2 Department of Pharmacy, The Second Xiangya Hospital of Central South University, Central South University, Changsha, Hunan, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8739-6236View further author information
ORCID Icon
Pages 1849-1857 | Received 07 Jul 2023, Accepted 01 Sep 2023, Published online: 12 Sep 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.